Jim Boonyaratanakornkit
banner
jimboonya.bsky.social
Jim Boonyaratanakornkit
@jimboonya.bsky.social
Principal investigator and infectious disease specialist @FredHutch studying respiratory viruses and herpes viruses to help improve the care of vulnerable patients #sniffledoctor
https://research.fredhutch.org/boonyaratanakornkit/en.html
Key paper on the impact of respiratory viral infections on lung function in bone marrow transplant patients published by my colleagues @fredhutch.org pubmed.ncbi.nlm.nih.gov/41027579/
Respiratory Virus Infections and Pulmonary Impairment after Allogeneic Hematopoietic Cell Transplantation - PubMed
RVI after HCT, particularly those caused by RSV, PIV-3 and influenza, increase the risk of pulmonary impairment and mortality. These infections should be targeted for specific anti-viral approaches an...
pubmed.ncbi.nlm.nih.gov
October 1, 2025 at 5:21 PM
Cheers to Chandler! Thanks for helping set up the @fredhutch.bsky.social VIDD-Clinical Research Center. Best wishes at OHSU. Looking forward to seeing the great things you will do there.
September 9, 2025 at 4:35 PM
Walked up to my office the other day and this made me smile. Thanks lab, you guys are awesome @fredhutch.bsky.social
September 4, 2025 at 8:12 PM
Reposted by Jim Boonyaratanakornkit
August 9, 2025 at 5:23 PM
I'm riding in the @obliteride.bsky.social this weekend to support cancer research and care @fredhutch.bsky.social. Check out my page and, if you'd like, make a donation that will fuel cancer research.
secure.fredhutch.org/goto/Jim_Boon
August 8, 2025 at 7:44 AM
Academic/industry partnerships @fredhutch.bsky.social through the Evergreen Fund drive innovation, collaboration, and research with real world impact. Grateful for the opportunity to accelerate antibody development to respiratory viruses for our transplant community
www.fredhutch.org/en/news/rele...
Fred Hutch Cancer Center announces 2025 Evergreen Fund awardees
Fred Hutch Cancer Center announces 2025 Evergreen Fund awardees, nine Fred Hutch researchers receive funding totaling $1.175 million for projects with commercial partnership potential.
www.fredhutch.org
June 16, 2025 at 7:33 PM
Check out what's new from our lab @fredhutch.bsky.social www.biorxiv.org/content/10.1... with 1-minute audio summary sciencecast.org/casts/0aqdo7... We discovered a highly potent antibody that can be used as prevention and treatment for a common respiratory virus called human metapneumovirus.
DEVELOPMENT OF A POTENT MONOCLONAL ANTIBODY FOR TREATMENT OF HUMAN METAPNEUMOVIRUS INFECTIONS
Human metapneumovirus (HMPV) is a major cause of respiratory infections, particularly among vulnerable populations, yet effective therapeutics remain unavailable. Monoclonal antibodies (mAbs) offer a ...
www.biorxiv.org
June 12, 2025 at 12:37 AM
I'm riding my single gear bike (donated by my brother) over the hills of Seattle in the @obliteride.bsky.social on August 9th to support the @fredhutch.bsky.social Cancer Center, where I work. Below is my personal page. If you would like, you can donate. My best. secure.fredhutch.org/site/TR?px=1...
Jim Boonyaratanakornkit
Help Fred Hutch Cancer Center advance innovative research. Donate today!
secure.fredhutch.org
April 3, 2025 at 3:30 PM
Are you a workstudy college student or know one who is interested in a career in the biological sciences? Our lab has a position open for a lab aide. Application here: careers-fhcrc.icims.com/jobs/29313/l...

Lab website: research.fredhutch.org/boonyaratana...
Fred Hutchinson Cancer Center
Fred Hutch is dedicated to the elimination of cancer and related diseases as causes of human suffering and death.
careers-fhcrc.icims.com
March 24, 2025 at 5:30 PM
Reposted by Jim Boonyaratanakornkit
Francis Collins, former longtime director of the National Institutes of Health, announced Saturday that he has retired

www.statnews.com/2025/03/01/n...
Former director Francis Collins retires from NIH, urging 'respect' for embattled workers
Francis Collins, former longtime director of the National Institutes of Health, announced Saturday that he has retired
www.statnews.com
March 2, 2025 at 2:49 AM
Reposted by Jim Boonyaratanakornkit
Flu season isn't over yet, & it's important for kids & adults to get vaccinated. “With COVID-19, we got used to the idea that the very old are the only people who are at risk for getting seriously ill," UCSF's Dr. Peter Chin-Hong says. But with flu, "it's... also the very young.”
ucsfh.org/4i1baA0
Flu deaths now exceeding COVID-19 deaths
Public health experts worry about low vaccination uptake and that the season is far from over.
ucsfh.org
February 21, 2025 at 6:07 PM
Thanks for a fabulous and productive scientific, clinical, and patient centered Tandem2025 conference by @astct.bsky.social we’ll miss you Hawaii. Lab dinner at the beach before we return to Seattle.
February 16, 2025 at 5:55 PM
Great talk and title by Elizabeth Eubanks “Raising the Epstein Barr” from @dukemedschool.bsky.social @astct.bsky.social on therapies for relapsed refractory EBV post-transplant lymphoproliferative disease. Calling on Andy McGuire Lab @fredhutch.bsky.social to develop your therapeutic antibodies!
February 16, 2025 at 2:21 AM
Interesting results presented by Elizabeth Krantz from @joshhillmd.bsky.social team @fredhutch.bsky.social @astct.bsky.social Tandem2025. Overall antibody levels are low in CAR T recipients. Re-vaccination is important. The Boonya lab collaborated on the B cell analysis.
February 15, 2025 at 9:49 PM
Highlights from Justine Ross’ presentation from @cityofhope.bsky.social on RSV infections at Tandem2025 @astct.bsky.social 1) most respiratory viral infections occur during months 1-3 post-CAR T-cell therapy; 2) we need studies on RSV mAbs and vaccines in transplant and cell therapy recipients
February 15, 2025 at 8:59 PM
Engaging talk by Jen Adair @fredhutch.bsky.social Tandem2025 @astct.bsky.social on efforts to make cell and gene therapy available in low and middle income countries. Academic centers need to step up. Great to see my friend @cgtgaithersburg.bsky.social in the Global Gene Therapy Initiative
February 15, 2025 at 8:03 PM
Reposted by Jim Boonyaratanakornkit
Fred Hutch at #Tandem25: Dr. Masumi Ueda Oshima to present results of a novel drug regimen that shows great promise in preventing #cGVHD after transplant in people who received nonmyeloablative or reduced-intensity conditioning to treat a blood cancer. bit.ly/411oqO2
February 14, 2025 at 7:06 PM
Reposted by Jim Boonyaratanakornkit
Meet the next generation of hematology and oncology leaders! The Fred Hutch/UW Hematology-Oncology Fellows are at #Tandem25 presenting their latest findings in transplantation, cell therapies, immunology and more.🩸🔬🥼 Meeting highlights: bit.ly/4aTobco

#OncSky
February 15, 2025 at 4:47 PM
Brief lab excursion from @astct.bsky.social to hike up Diamond Head State Monument and appreciate the beauty of Hawaii.
February 15, 2025 at 1:21 AM
Beautiful best oral abstract by Masumi Oshima @fredhutch.bsky.social in a giant ballroom @astct.bsky.social on how post-transplant cytoxan significantly reduces chronic graft vs host disease but increases rates of infection.
February 15, 2025 at 1:18 AM
The Boonya lab @fredhutch.bsky.social Tandem2025 reception @astct.bsky.social Thanks Dr. Geoff Hill for hosting! The poke bar was delish!
February 14, 2025 at 7:17 PM
Superb discussion around our poster on how GVHD prophylaxis and low antibody levels can increase risk for RSV infection after stem cell transplant @astct.bsky.social with Sara Pernikoff, Annie Clurman, Filipo Milano @fredhutch.bsky.social and Oriana Miltiadous @mskcancercenter.bsky.social
February 14, 2025 at 7:15 PM
Reposted by Jim Boonyaratanakornkit
Fred Hutch at #Tandem25: Catch Dr. Fred Appelbaum present "How We Got Here: Don Thomas, Marrow Transplantation & the Cell Therapy Revolution." Details: bit.ly/4hz8OZc
February 13, 2025 at 4:34 PM
Reposted by Jim Boonyaratanakornkit
Fred Hutch at #Tandem25: Catch presentations from Drs.
Julie Boiko, Rachel Salit, @simone-minnie.bsky.social and Marie Bleakley on cGVHD biology, basic science of GVL and post-HCT immune microenvironment, T cell responses to minor histocompatibility antigens & more 👉 bit.ly/3EAM24L
February 13, 2025 at 8:00 PM
Fantastic oral abstract by Stosh Ozog from @joshhillmd.bsky.social group @fredhutch.bsky.social @astct.bsky.social In CAR T-cell recipients, CD19 B cell counts are the primary predictor of vaccine responses (Sara Pernikoff in the Boonya Lab collaborated on this work)
February 14, 2025 at 1:47 AM